ICON Plc Buyback
OLI recorded this information on 9/19/2014
ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced today that it has completed a $40 million buyback of the Company's ordinary shares through open market acquisitions at an average price of $49.87. In addition, the Company announced a further program under which the Company can acquire (by way of redemption) up to an additional $100 million of its outstanding ordinary shares through open market share acquisitions.
Icon is a clinical research organization. Co. operates as one business segment, which is the provision of outsourced development services on a global basis to the pharmaceutical, biotechnology and medical devices industries. Co. provides a range of clinical, consulting and commercial services that range from clinical development strategy, planning and trial design, to full study execution, and post-market commercialization. Co. engages in the development, management and analysis of programs that support various stages of the clinical development process. Co. provides services including clinical trial management, consulting, contract staffing and laboratory services.
Open the ICLR Page at The Online Investor »
Buy (3.17 out of 4)